Proteins play a key role in the life sciences – from basic research and biotechnological applications to the development and manufacturing of pharmaceuticals.
AstraZeneca receives China’s NMPA approval for Forxiga
AstraZeneca’s Forxiga is indicated for treating individuals with chronic kidney disease, type 2 diabetes and HFrEF in more than 100 countries globally. Credit: AstraZeneca. AstraZeneca